Research Assistant Professor/ PI
National Hellenic Research Foundation, Greece
The team works on 3D cancer models, multi-omics and information technologies synergies. Emphasis is put on translating information growth to knowledge growth. Our vision is to define the 'actionable-ome' and to unmask cancer. Our mission is to map inter-individual variability and to delineate disease phenotypes. From early discovery stages through clinical support and drug discovery, optimal decision- and sense-making become of fundamental importance for tailor-made theranostics and patient stratification. Biomarkers represent a key strategy for innovation and knowledge creation.
Existing collaborations relevant to drug delivery
Operational Program Competitiveness, Entrepreneurship and Innovation, RESEARCH-CREATE- INNOVATE (Τ2EΔK-03153) “Cloudscreen: A platform for Drug Repurposing” May 2020-Nov2022
Publications relevant to drug delivery
Email for contact details